Donor-specific allogeneic hematopoietic cell transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor-specific allogeneic hematopoietic cell transplantation, covering 2018-07-20 to 2018-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL) [Phase 2]